Is Patients’ Preferred Involvement in Health Decisions Related to Outcomes for Patients with HIV?
Previous studies suggest that patients who are more involved in their medical care have better outcomes.
We sought to compare health care processes and outcomes for patients with HIV based on their preferred level of involvement in health decisions.
Cross-sectional analysis of audio computer-assisted interviews with patients at an urban HIV clinic.
One thousand and twenty-seven patients awaiting an appointment with their primary care provider.
Patients were asked how they preferred to be involved in decisions (doctor makes most or all decisions, doctor and patient share decisions, patient makes all decisions). We also asked patients to rate the quality of communication with their HIV provider, and their self-reported receipt of and adherence to HAART.
Overall, 23% patients preferred that their doctor make all or most decisions, 63% preferred to share decisions with their doctor, and 13% preferred to make all final decisions alone. Compared to patients who prefer to share decisions with their HIV provider, patients who prefer that their provider make all/most decisions were significantly less likely to adhere to HAART (OR [odds ratio] 0.57, 95% CI 0.38–0.86) and patients who preferred to make decisions alone were significantly less likely to receive HAART or to have undetectable HIV RNA in unadjusted analyses (OR 0.52, 95% CI 0.31–0.87 for receipt of HAART; OR 0.64, 95% CI 0.44–0.95 for undetectable HIV RNA). After controlling for potentially confounding patient characteristics and differences in patient ratings of communication quality, patients who preferred that their provider make all/most decisions remained significantly less likely to adhere to HAART (OR 0.58, 95% CI 0.38–0.89); however, the associations with receipt of HAART and undetectable HIV RNA were no longer significant (OR 0.60, 95% CI 0.34–1.05 for receipt of HAART; OR 0.80, 95% C.I 0.53–1.20 for undetectable HIV RNA).
Although previous research suggests that more patient involvement in health care decisions is better, this benefit may be reduced when the patient wants to make decisions alone. Future research should explore the extent to which this preference is modifiable so as to improve outcomes.
KEY WORDSpatient involvement in care patient–provider relationship HIV medication adherence
Dr. Beach is a Robert Wood Johnson Generalist Physician Faculty Scholar and a recipient of a K-08 grant from the Agency for Healthcare Research and Quality. Other grant support: National Institutes of Health R01 DA11602, K24 DA11602, R21 AA105032.
Conflict of Interest
- 15.U.S.Department of Health and Human Services (DHHS). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. URL: http://aidsinfo.nih.gov (accessed 13 Apr 2005).
- 16.Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000 12(3):255–66.PubMedCrossRefGoogle Scholar
- 18.Beach MC, Keruly J, Moore RD. Is the quality of the patient–provider relationship associated with better adherence and improved health outcomes for patients with HIV? J Gen Intern Med 2006 (in press).Google Scholar
- 20.Collins KS, Hughes DL, Doty MM, Ives BL, Edwards JN, Tenney K. Diverse Communities, Common Concerns: Assessing health care quality for minority Americans. New York: The Commonwealth Fund; 2002.Google Scholar